Fractalkine and TGF-β1 levels reflect the severity of chronic pancreatitis in humans

World Journal of Gastroenterology

Volumn 14, Issue 42, 2008, Pages 6488-6495

  Yasuda, Mikihiko ^a   Ito, Tetsuhide ^a   Oono, Takamasa ^a   Kawabe, Ken ^a   Kaku, Toyoma ^a   Igarashi, Hisato ^a   Nakamura, Taichi ^a   Takayanagi, Ryoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Chronic pancreatitis; Monocyte chemoattractant protein 1; Soluble fractalkine; Transforming growth factor beta 1

Indexed keywords

FRACTALKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; CX3CL1 PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; ALCOHOLIC PANCREATITIS; BLOOD; CASE CONTROL STUDY; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CX3CL1; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS, ALCOHOLIC; PANCREATITIS, CHRONIC; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 63449139617     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.6488     Document Type: Article

References (44)

1. Clain JE, Pearson RK. Diagnosis of chronic pancreatitis. Is a gold standard necessary? Surg Clin North Am 1999; 79: 829-845
2. Chari ST, Singer MV. The problem of classification and staging of chronic pancreatitis. Proposals based on current knowledge of its natural history. Scand J Gastroenterol 1994; 29: 949-960
3. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682-707
4. Sarles H. Pancreatitis. Symposium; 1963 April; Marseille, France. Basel: Karger, 1965, 7: 1-20
5. Nakano S, Horigauchi Y, Takeda T, Suzuki T, Nakajima S. Comparative diagnostic value of endoscopic pancreatography and pancreatic function tests. Scand J Gastroenterol 1974; 9: 383-390
6. Heij HA, Obertop H, van Blankenstein M, Nix GA, Westbroek DL. Comparison of endoscopic retrograde pancreatography with functional and histologic changes in chronic pancreatitis. Acta Radiol 1987; 28: 289-293
7. Ito T. Can measurement of chemokines become useful biological and functional markers of early-stage chronic pancreatitis? J Gastroenterol 2007; 42 Suppl 17: 72-77
8. Ito T, Otsuki M, Itoi T, Shimosegawa T, Funakoshi A, Shiratori K, Naruse S, Kuroda Y. Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan. J Gastroenterol 2007; 42: 291-297
9. Malfertheiner P, Büchler M. Correlation of imaging and function in chronic pancreatitis. Radiol Clin North Am 1989; 27: 51-64
10. Grady T, Liang P, Ernst SA, Logsdon CD. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 1997; 113: 1966-1975
11. Saurer L, Reber P, Schaffner T, Büchler MW, Buri C, Kappeler A, Walz A, Friess H, Mueller C. Differential expression of chemokines in normal pancreas and in chronic pancreatitis. Gastroenterology 2000; 118: 356-367
12. Otsuki M. Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems. J Gastroenterol 2003; 38: 315-326
13. Hayakawa T, Kondo T, Shibata T, Noda A, Suzuki T, Nakano S. Relationship between pancreatic exocrine function and histological changes in chronic pancreatitis. Am J Gastroenterol 1992; 87: 1170-1174
14. Hayakawa T, Kitagawa M, Naruse S, Ishigyrro H, Mizuno N, Nakajima M. Staging of chronic pancreatitis (in Japanese). Suizou (J Jpn Pancreas Soc) 2001; 16: 381-385
15. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210
16. Inoue M, Ino Y, Gibo J, Ito T, Hisano T, Arita Y, Nawata H. The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats. Pancreas 2002; 25: e64-e70
17. Gibo J, Ito T, Kawabe K, Hisano T, Inoue M, Fujimori N, Oono T, Arita Y, Nawata H. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. Lab Invest 2005; 85: 75-89
18. Zhao HF, Ito T, Gibo J, Kawabe K, Oono T, Kaku T, Arita Y, Zhao QW, Usui M, Egashira K, Nawata H. Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Gut 2005; 54: 1759-1767
19. Kaku T, Oono T, Zhao H, Gibo J, Kawabe K, Ito T, Takayanagi R. IS-741 attenuates local migration of monocytes and subsequent pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Pancreas 2007; 34: 299-309
20. Pedersen N, Larsen S, Seidelin JB, Nielsen OH. Alcohol modulates circulating levels of interleukin-6 and monocyte chemoattractant protein-1 in chronic pancreatitis. Scand J Gastroenterol 2004; 39: 277-282
21. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641
22. di Mola FF, Friess H, Martignoni ME, Di Sebastiano P, Zimmermann A, Innocenti P, Graber H, Gold LI, Korc M, Büchler MW. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg 1999; 230: 63-71
23. Shek FW, Benyon RC, Walker FM, McCrudden PR, Pender SL, Williams EJ, Johnson PA, Johnson CD, Bateman AC, Fine DR, Iredale JP. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol 2002; 160: 1787-1798
24. Apte MV, Wilson JS. Mechanisms of pancreatic fibrosis. Dig Dis 2004; 22: 273-279
25. Madro A, Celiński K, Słomka M. The role of pancreatic stellate cells and cytokines in the development of chronic pancreatitis. Med Sci Monit 2004; 10: RA166-RA170
26. Su SB, Motoo Y, Xie MJ, Miyazono K, Sawabu N. Expression of transforming growth factor-beta in spontaneous chronic pancreatitis in the WBN/Kob rat. Dig Dis Sci 2000; 45: 151-159
27. Detlefsen S, Sipos B, Feyerabend B, Klöppel G. Fibrogenesis in alcoholic chronic pancreatitis: the role of tissue necrosis, macrophages, myofibroblasts and cytokines. Mod Pathol 2006; 19: 1019-1026
28. Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J. Cytokines and alcohol. Alcohol Clin Exp Res 2006; 30: 720-730
29. Apte MV, Zima T, Dooley S, Siegmund SV, Pandol SJ, Singer MV. Signal transduction in alcohol-related diseases. Alcohol Clin Exp Res 2005; 29: 1299-1309
30. Rossi DL, Hardiman G, Copeland NG, Gilbert DJ, Jenkins N, Zlotnik A, Bazan JF. Cloning and characterization of a new type of mouse chemokine. Genomics 1998; 47: 163-170
31. Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR, Strijbos PJ. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci 2000; 20: RC87
32. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521-530
33. Ludwig A, Berkhout T, Moores K, Groot P, Chapman G. Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity. J Immunol 2002; 168: 604-612
34. Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 34-40
35. Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 2005; 41: 506-516
36. Rimaniol AC, Till SJ, Garcia G, Capel F, Godot V, Balabanian K, Durand-Gasselin I, Varga EM, Simonneau G, Emilie D, Durham SR, Humbert M. The CX3C chemokine fractalkine in allergic asthma and rhinitis. J Allergy Clin Immunol 2003; 112: 1139-1146
37. Ito Y, Kawachi H, Morioka Y, Nakatsue T, Koike H, Ikezumi Y, Oyanagi A, Natori Y, Natori Y, Nakamura T, Gejyo F, Shimizu F. Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. Kidney Int 2002; 61: 2044-2057
38. Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Göke B, Ochsenkühn T, Lohse P. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype. Am J Gastroenterol 2006; 101: 99-106
39. Hulshof S, van Haastert ES, Kuipers HF, van den Elsen PJ, De Groot CJ, van der Valk P, Ravid R, Biber K. CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J Neuropathol Exp Neurol 2003; 62: 899-907
40. Echigo T, Hasegawa M, Shimada Y, Takehara K, Sato S. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. J Allergy Clin Immunol 2004; 113: 940-948
41. Kastenbauer S, Koedel U, Wick M, Kieseier BC, Hartung HP, Pfister HW. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J Neuroimmunol 2003; 137: 210-217
42. Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations. Arthritis Rheum 2005; 52: 1670-1675
43. Matsunawa M, Isozaki T, Odai T, Yajima N, Takeuchi HT, Negishi M, Ide H, Adachi M, Kasama T. Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis. Arthritis Rheum 2006; 54: 3408-3416
44. Gangemi S, Cannavò SP, Guarneri F, Merendino RA, Sturniolo GC, Minciullo PL, Di Pasquale G, Valenzise M, Drago F, Rebora A. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea. J Eur Acad Dermatol Venereol 2006; 20: 1366-1367